Building Rapid Inpatient Delivery of ART to Generate Engagement in HIV Care

Part of paid clinical trials in Chicago, Illinois.

Sponsor
University of Chicago
Study ID
NCT07847567
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • HIV Treatment

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The study team will pilot rapid antiretroviral therapy (ART) initiation as part of routine inpatient care at the University of Chicago Medicine (UCM), comparing outcomes over a 12-month implementation period. Electronic medical record (EMR) data will be used to evaluate clinical outcomes such as ART initiation within 24-48 hours, linkage to HIV care, retention, and viral suppression, as well as demographic and clinical factors associated with these outcomes. Implementation outcomes will be assessed using Proctor's framework, including acceptability, feasibility, fidelity, and appropriateness.

Key Dates

First listed
Sep 29, 2026
Start date
Feb 28, 2027
Status verified
Sep 2026
Primary completion
Feb 29, 2028
Completion
May 31, 2028

Study Design

Enrollment
40 participants (estimated)

Primary Outcome Measure

Proportion of eligible inpatients with HIV who are started on ART within 24-48 hours of qualifying hospitalization [ Time Frame: Baseline to month 12 ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of ChicagoChicagoIllinois60637-

Find similar trials in Chicago, IL

By research site
University of Chicago· Chicago, IL

Related Studies